- PRICING
- LIVE QUOTES
- LEARN
- HELP
EN
After Raising Guidance in April, What Has Cerus Left to Say Tomorrow?
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
CERS reports after market close, meaning Day 0 reflects anticipatory trading before results are known, while Day +1 captures the market's first full reaction to the actual numbers.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-04-30 | +$0.11 (+5.73%) | $0.13 (6.77%) | +$0.69 (+33.99%) | $0.68 (33.50%) |
| 2026-03-02 | -$0.03 (-1.17%) | $0.15 (5.86%) | -$0.40 (-15.81%) | $0.36 (14.23%) |
| 2025-08-05 | -$0.02 (-1.54%) | $0.09 (6.92%) | +$0.01 (+0.78%) | $0.11 (8.59%) |
| 2025-05-01 | -$0.02 (-1.52%) | $0.04 (3.03%) | +$0.05 (+3.85%) | $0.10 (7.69%) |
| 2025-02-20 | -$0.07 (-3.87%) | $0.07 (4.14%) | -$0.09 (-5.17%) | $0.28 (16.09%) |
| 2024-10-30 | +$0.02 (+1.18%) | $0.15 (8.78%) | -$0.15 (-8.72%) | $0.27 (15.70%) |
| 2024-08-01 | -$0.22 (-9.73%) | $0.28 (12.39%) | +$0.31 (+14.95%) | $0.45 (22.06%) |
| 2024-05-02 | N/A | N/A | N/A | N/A |
| Avg Abs Move | 3.53% | 6.84% | 11.90% | 16.84% |
Historical price action around earnings shows significant volatility, with the average absolute Day +1 move of 11.90% substantially exceeding the Day 0 move of 3.53%. The most recent earnings release on April 30, 2026, exemplifies this pattern: the stock moved modestly higher by 5.73% on Day 0, then surged 33.99% on Day +1 following the better-than-expected results.
The direction of moves has been mixed but increasingly positive. The March 2026 report triggered a sharp -15.81% decline, while earlier reports in 2025 showed more muted reactions. The wide Day +1 range of 16.84% on average indicates CERS can swing dramatically in either direction depending on results and guidance, with individual moves ranging from -15.81% to +33.99% over the past year. Investors should prepare for substantial volatility following tomorrow's after-hours release.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 23) |
| Expected Move | $0.22 (7.70%) |
| Expected Range | $2.65 to $3.09 |
| Implied Volatility | 159.33% |
The options market is pricing a 7.70% expected move (±$0.22, range $2.65-$3.09) through the August 21 expiration, which is substantially below the stock's average historical Day +1 earnings move of 11.90%. This suggests options traders may be underpricing potential volatility, particularly given the 33.99% surge following the most recent April earnings beat.
Part 3: What Analysts Are Saying
Analysts maintain a bullish stance on CERS with an average rating of 4.50 (Strong Buy territory), supported by 3 Strong Buy ratings, 0 Moderate Buys, 1 Hold, and no Sell ratings among the 4 analysts covering the stock. The consensus price target of $4.67 implies 63% upside from the current price of $2.87, with individual targets ranging from $4.00 to $5.00.
Sentiment has remained unchanged over the past month, with the Strong Buy-heavy rating distribution holding steady. This stability suggests analysts are maintaining conviction in their bullish thesis despite the stock's recent pullback from higher levels. The tight clustering of price targets ($4.00-$5.00) indicates broad agreement on valuation, with all analysts seeing substantial appreciation potential as the company progresses toward profitability. The unanimous absence of any Sell ratings underscores confidence in CERS's business trajectory and the commercial opportunity for its blood safety technologies.
Part 4: Technical Picture
The Barchart Technical Opinion currently shows a Buy signal at 80%, down from 88% one week ago and 100% one month ago, indicating recent weakening in technical momentum as the stock has pulled back from recent highs. CERS is trading at $2.87, positioned below its short-term moving averages but above longer-term trend lines.
Timeframe Analysis:
- Short-term (50% Buy): Moderate buy signal reflects mixed near-term momentum as the stock consolidates below recent peaks
- Medium-term (100% Buy): Strong buy signal indicates solid intermediate-term uptrend remains intact despite recent softness
- Long-term (100% Buy): Strong buy signal confirms the broader uptrend is well-established, supported by the stock's position well above its 200-day average
Trend Characteristics: The Strong trend that is currently Weakening suggests CERS maintains a solid technical foundation but faces near-term headwinds heading into earnings, creating a setup where results could either reinvigorate momentum or trigger further consolidation.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $2.93 | 50-Day MA | $2.86 |
| 10-Day MA | $3.03 | 100-Day MA | $2.44 |
| 20-Day MA | $3.09 | 200-Day MA | $2.22 |
The stock is trading below its 5-day ($2.93), 10-day ($3.03), and 20-day ($3.09) moving averages, indicating recent weakness, but remains above its 50-day ($2.86), 100-day ($2.44), and 200-day ($2.22) moving averages, confirming the longer-term uptrend is intact. The 50-day average at $2.86 now serves as immediate support, just $0.01 below the current price. This technical setup is cautiously supportive for earnings: while the pullback from the $3.09 level has created overhead resistance, the stock's position above key longer-term averages provides a cushion. A strong earnings beat could quickly reclaim the 20-day average and resume the uptrend, while a disappointment risks breaking below the critical 50-day support level.